Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
REGN3470-3471-3479
BIOLOGICAL
2 trials
Sponsors
Regeneron Pharmaceuticals
Conditions
Ebola Virus Disease
Healthy Volunteers
Phase 1
Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers
Completed
NCT02777151
Regeneron Pharmaceuticals
Healthy Volunteers
Start: 2016-05-27
End: 2017-04-26
Updated: 2018-02-05
Unknown Phase
R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease
NCT03576690
Regeneron Pharmaceuticals
Ebola Virus Disease
Updated: 2025-11-24